𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab

✍ Scribed by Timothy Poterucha, Brian Burnette, Aminah Jatoi

Book ID
113093661
Publisher
Springer US
Year
2011
Tongue
English
Weight
248 KB
Volume
29
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cancer markers in patients receiving che
Cancer markers in patients receiving chemotherapy for colorectal cancer: A preliminary report
✍ Bullen, B. R. ;Cooper, E. H. ;Turner, R. ;Neville, A. M. ;Giles, G. R. ;Hall, R. πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 656 KB

## Abstract The combination of CEA, hepatic function marker enzymes, and four acute phase reactant proteins (haptoglobin, Ξ±~1~ antitrypsin, Ξ±~1~ acid glycoprotein, and prealbumin) has been used to monitor patients with colorectal cancer receiving chemotherapy. In 18 patients with advanced lesions